<DOC>
	<DOC>NCT00557401</DOC>
	<brief_summary>To evaluate efficacy and safety of treatment with XP19986 Sustained Release (SR) Tablet compared to placebo in subjects with symptomatic GERD</brief_summary>
	<brief_title>An Efficacy and Safety Study of XP19986 in Subjects With Symptomatic GERD</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Arbaclofen placarbil</mesh_term>
	<mesh_term>Baclofen</mesh_term>
	<criteria>History and documentation of GERD diagnosed by a gastroenterologist, with symptoms (heartburn and/or regurgitation) on â‰¥ 3 days during the week prior to screening and prior to randomization Current or historical endoscopic evidence of erosive esophagitis LA Classification Grade B, C, or D</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>